QT Imaging is reporting steady revenue for the second quarter of the 2024 fiscal year, as well as highlighting new partnerships and distribution agreements.
The company reported that its commercial revenue for the quarter (end-June 30) was $1.7 million, compared with $1.4 million in the first quarter and less than $100,000 for the second quarter of 2023. QT also reported a net loss of $1.2 million for the most recent quarter.
Among QT's highlights for the time period include entering a distribution agreement with NXC Imaging. Under this agreement, NXC is the exclusive reseller to market, advertise, and resell QT Breast Acoustic CT scanners in the U.S. and U.S. Territories. QT Imaging also announced a partnership with the Vincere Cancer Center in Scottsdale, AZ, together with its strategic distribution partner.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
